293736-67-1

293736-67-1 structure

Name: RTA 744
Chemical Name: (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-6-methyl-5-phenylmethoxyoxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione,hydrochloride
CAS Number: 293736-67-1
Molecular Formula: C₃₄H₃₆ClNO₁₁
Molecular Weight: 670.10300
Catalog: Signaling Pathways Apoptosis Apoptosis
Create Date: 2017-10-21 01:48:29
Modify Date: 2024-04-06 11:34:30
RTA 744 (WP 744) is a Doxorubicin (HY-15142A) analogue. RTA 744 triggers apoptosis and cell killing in NB cells by activating proapoptotic mediators. RTA 744 has proapoptotic and anti-leukemia activities. RTA 744 can be used for cancer research[1][2][3].

Name	(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-6-methyl-5-phenylmethoxyoxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione,hydrochloride
Synonyms	Berubicin HCl WP744 RTA-744 Berubicin hydrochloride (USAN)

Description	RTA 744 (WP 744) is a Doxorubicin (HY-15142A) analogue. RTA 744 triggers apoptosis and cell killing in NB cells by activating proapoptotic mediators. RTA 744 has proapoptotic and anti-leukemia activities. RTA 744 can be used for cancer research[1][2][3].
Related Catalog	Signaling Pathways >> Apoptosis >> Apoptosis Research Areas >> Cancer
In Vitro	WP 769 hydrochloride 抑制 K562 细胞的活性，IC50 值为 0.18 mg/mL[1]。 WP 769 hydrochloride (0-100 µM；24 h) 抑制 KBM-5 细胞吸收胸腺嘧啶[2]。 WP 769 hydrochloride (1 µM；15 min) 在 KBM-5 细胞中通过 NF-κB 的 p50 和 p65 亚基激活 NF-κB[2]。 WP 769 hydrochloride (0-100 µM；72 h) 以剂量依赖性方式抑制 Jurkat 和 RIP 缺失的 Jurkat 细胞增值[2]。 Cell Viability Assay[2] Cell Line: KBM-5 cells. Concentration: 0, 0.1, 1, 10 and 100 µM. Incubation Time: 24 h. Result: Inhibited cell viability with dose-dependent manner. Western Blot Analysis[2] Cell Line: KBM-5 cells. Concentration: 0, 0.1, 1 and 10 µM. Incubation Time: 4 h. Result: Increased NF-κB expression with time and dose dependent manner. Cell Viability Assay[3] Cell Line: SH-SY5Y cells. Concentration: 0.1, 1 and 10 µM. Incubation Time: 0, 1, 2, 3, 4 and 5 d. Result: Inhibited cell viability with dose-dependent manner. Apoptosis Analysis[3] Cell Line: SH-SY5Y cells. Concentration: 50, 500 and 2000 nM. Incubation Time: 48 h. Result: Promoted cell apoptosis. Western Blot Analysis[3] Cell Line: SH-SY5Y cells. Concentration: 0, 0.1, 1.0 or 10 µM. Incubation Time: 0, 0.5, 1, 2, 4, 6, 8, 12 or 24 h. Result: Activated Casp 3 and Casp 9. Increased p53 and NF-κB expression. Reduced IκBα expression.
References	[1]. Faderl S, et al. WP744, a novel anthracycline with enhanced proapoptotic and antileukemic activity. Anticancer Res. 2001 Nov-Dec;21(6A):3777-84. [2]. Ashikawa K, et al. Evidence that activation of nuclear factor-kappaB is essential for the cytotoxic effects of doxorubicin and its analogues. Biochem Pharmacol. 2004 Jan 15;67(2):353-64. [3]. Wu J, Harris NL, Inge TH. Nuclear factor-kappa B and apoptosis inducing factor activation by doxorubicin analog WP744 in SH-SY5Y neuroblastoma cells. J Surg Res. 2004 Dec;122(2):231-9.

Molecular Formula	C₃₄H₃₆ClNO₁₁
Molecular Weight	670.10300
Exact Mass	669.19800
PSA	195.07000
LogP	3.72810

293736-67-1	1474034-05-3
1346669-54-2	2138861-99-9
1177806-11-9	85371-61-5
93821-56-8	216862-58-7
9013-05-2	1398-61-4
1158522-08-7	2227757-11-9
940364-43-2	134104-43-1
131615-57-1	6906-52-1
930439-75-1	1018584-77-4
1375289-11-4	2034387-72-7